JPRN-UMIN000004094已完成未知
Exploratory trials evaluating the pharmacokinetics of Quinidine and Verapamil after oral administration in healthy male subjects - Exploratory trials evaluating the pharmacokinetics of Quinidine and Verapamil after oral administration in healthy male subjects
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- APDD
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 45years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •The following subjects shall be excluded from this study: (1)The subject has any medical history that is not considered as eligible for inclusion in this study by the investigator. (2)The subject has the disease which needs a treatment at present. (3)The subject is currently participating in another clinical study and is exposed to an investigational drug. (4) The subject has any medical history of known allergy or hypersensitivity to quinidine, verapamil, fexofenadine, midazolam, celiprorol and itraconazole. (5) The subject has donated whole blood">400mL" within the previous 3 months or ">200mL" within the previous 1 month, and components of blood(apheresis) within the previous 2 weeks. (6) The subject has hypersensitivity to any drugs and foods. (7) The subject has a history or current conditions of drug abuse or alcoholism. (8)The subject is positive for HBs antigen, syphilis, HCV antibody, HIV antigen/antibody. (9)The subject has any clinically relevant abnormality on vital sign, clinical laboratory test, ECG and medical examination. (The subject who admitted participation in this study in the judgement of investigator excludes.) (10)Any subjects considered to be unsuitable for the study by the reseacher.
研究者
相似试验
进行中（未招募）
不适用
The Pharmacokinetic Study of the Fixed-dose Combination of Micronized Fenofibrate and Pitavastatin CaDiseases of the circulatory systemKCT0001258Hanlim Pharmaceutical40
已完成
不适用
A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402KCT0003213avipharm38
进行中（未招募）
不适用
A trial investigating the pharmacokinetic properties of FIAsp in children, adolescents and adults with type 1 diabetesDiabetes Mellitus, Type 1MedDRA version: 16.0Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861EUCTR2011-002104-32-DEovo Nordisk A/S
已完成
不适用
Clinical study to investigate the pharmacokinetics, efficacy, safety and immunogenicity of human-cl rhFVIII in previously treated patients with severe haemophilia ASevere haemophilia AHaematological DisordersHereditary factor VIII deficiencyISRCTN87293301Octapharma AG (Switzerland)20
进行中（未招募）
不适用
A study in Rheumatoid Arthritis patients to look at two formulations of adalimumab for pharmacokinetics and safety.MedDRA version: 14.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid ArthritisEUCTR2012-000535-36-CZAbbott GmbH & Co. KG100